
Invitrogen™ BODIPY™ 493/503 (4,4-Difluoro-1,3,5,7,8-Pentamethyl-4-Bora-3a,4a-Diaza-s-Indacene)
BODIPY™ 493/503 can be used as a stain for neutral lipds, and as a tracer for oil and other nonpolar lipids.
Invitrogen™ Ionomycin, Calcium Salt
Ionomycin is an effective Ca2+ ionopohre that is commonly used to both modify intracellular Ca2+ concentrations and to calibrate fluorescent Ca2+ indicators when studying the regulatory properties of Ca2+ in cellular processes.
Invitrogen™ Octadecyl Rhodamine B Chloride (R18)
Lipophilic octadecyl rhodamine B binds to membranes with fluorophore at aqueous interface and alkyl tail protruding into lipid interior
Content And Storage | -20°C |
---|---|
Purity or Quality Grade | ≥ 98% by SDS-PAGE gel and HPLC analyses. |
Conjugate | Unconjugated |
Form | Lyophilized |
Common Name | Oncostatin M |
Molecular Weight (g/mol) | 25.7 kDa |
Gene Symbol | OSM |
Endotoxin Concentration | <1 EU/ ÎĽg |
Sequence | AAIGSCSKEY RVLLGQLQKQ TDLMQDTSRL LDPYIRIQGL DVPKLREHCR ERPGAFPSEE TLRGLGRRGF LQTLNATLGC VLHRLADLEQ RLPKAQDLER SGLNIEDLEK LQMARPNILG LRNNIYCMAQ LLDNSDTAEP TKAGRGASQP PTPTPASDAF QRKLEGCRFL HGYHRFMHSV GRVFSKWGES PNRSRRHSPH QALRKGVRRT RPSRKGKRLM TRGQLPR |
Expression System | E. coli |
For Use With (Application) | ELISA,Functional Assay,Western Blot |
Source | E. coli |
Name | Human Oncostatin M (227 aa) |
Accession Number | P13725 |
Regulatory Status | RUO |
Gene Alias | MGC20461; OncoM; oncostatin M; oncostatin-M; OSM |
Biological Activity | The ED50 as determined by the dose-dependent stimulation of the proliferation of human TF-1 cells is ≤ 2 ng/ml, corresponding to a specific activity of ≥ 5 x 10^5 units/mg |
Gene ID (Entrez) | 5008 |
Formulation | protein with no preservative |
Recombinant | Recombinant |
Content And Storage | -20°C |
---|---|
Purity or Quality Grade | ≥ 95% by SDS-PAGE gel and HPLC analyses. |
Conjugate | Unconjugated |
Form | Lyophilized |
Common Name | Oncostatin M |
Molecular Weight (g/mol) | 22.2 kDa |
Gene Symbol | OSM |
Endotoxin Concentration | <1 EU/ ÎĽg |
Sequence | AAIGSCSKEY RVLLGQLQKQ TDLMQDTSRL LDPYIRIQGL DVPKLREHCR ERPGAFPSEE TLRGLGRRGF LQTLNATLGC VLHRLADLEQ RLPKAQDLER SGLNIEDLEK LQMARPNILG LRNNIYCMAQ LLDNSDTAEP TKAGRGASQP PTPTPASDAF QRKLEGCRFL HGYHRFMHSV GRVFSKWGES PNRSRR |
Expression System | HEK293 cells |
For Use With (Application) | Functional Assay |
Source | HEK293 cells |
Name | Human Oncostatin M (196 aa) |
Accession Number | P13725 |
Regulatory Status | RUO |
Gene Alias | MGC20461; OncoM; oncostatin M; oncostatin-M; OSM |
Biological Activity | Determined by its ability to stimulate the proliferation of human TF-1 cells. The expected ED50 is ≤ 2.0 ng/ml, corresponding to a specific activity of ≥ 5 x 10^5 units/mg |
Gene ID (Entrez) | 5008 |
Formulation | protein with no preservative |
Recombinant | Recombinant |
Content And Storage | -20°C |
---|---|
Purity or Quality Grade | ≥ 95% by SDS-PAGE gel and HPLC analyses. |
Conjugate | Unconjugated |
Form | Lyophilized |
Common Name | FGF23 |
Molecular Weight (g/mol) | 25.5 kDa |
Gene Symbol | FGF23 |
Endotoxin Concentration | <1 EU/ ÎĽg |
Sequence | MYPNASPLLG SSWGGLIHLY TATARNSYHL QIHKNGHVDG APHQTIYSAL MIRSEDAGFV VITGVMSRRY LCMDFRGNIF GSHYFDPENC RFQHQTLENG YDVYHSPQYH FLVSLGRAKR AFLPGMNPPP YSQFLSRRNE IPLIHFNTPI PRRHTRSAED DSERDPLNVL KPRARMTPAP ASCSQELPSA EDNSPMASDP LGVVRGGRVN THAGGTGPEG CRPFAKFI |
Expression System | E. coli |
For Use With (Application) | Functional Assay |
Source | E. coli |
Name | Human FGF-23 |
Accession Number | Q9GZV9 |
Regulatory Status | RUO |
Gene Alias | ADHR; FGF; Fgf23; FGF-23; FGFN; Fibroblast growth factor; Fibroblast growth factor 23; Fibroblast growth factor 23 C-terminal peptide; Fibroblast growth factor 23 N-terminal peptide; HPDR2; HYPF; Phosphatonin; PHPTC; tumor-derived hypophosphatemia inducing factor; Tumor-derived hypophosphatemia-inducing factor; UNQ3027/PRO9828 |
Biological Activity | Determined by its ability to stimulate the proliferation of murine NIH-3T3 cells. The expected ED50 for this effect is 2.0-5.0 ug/ml, in the presence of murine Klotho and heparin. |
Gene ID (Entrez) | 8074 |
Formulation | protein with no preservative |
Recombinant | Recombinant |
Shipping Condition | Room Temperature |
---|---|
Product Type | Inhibitor |
Recommended Storage | Store in freezer (-5°C to -30°C) |
Molecular Formula | C34H50O12 |
Label Type | Unlabeled |
Gibco™ Human IGF-I, Animal-Free Recombinant Protein, PeproTech®
Recombinant Protein
Content And Storage | -20°C |
---|---|
Purity or Quality Grade | ≥ 98% by SDS-PAGE gel and HPLC analyses. |
Conjugate | Unconjugated |
Form | Lyophilized |
Common Name | IGF1 |
Molecular Weight (g/mol) | 7.6 kDa |
Gene Symbol | IGF1 |
Endotoxin Concentration | <0.1 EU/ ÎĽg |
Sequence | GPETLCGAEL VDALQFVCGD RGFYFNKPTG YGSSSRRAPQ TGIVDECCFR SCDLRRLEMY CAPLKPAKSA |
Expression System | E. coli |
For Use With (Application) | Functional Assay |
Source | E. coli |
Name | Human IGF-I, Animal-Free |
Accession Number | P05019 |
Regulatory Status | RUO |
Gene Alias | C730016P09Rik; class 1 insulin-like growth factor I preproprotein; class 2 insulin-like growth factor I preproprotein; H-IGF-1; IBP1; IGF; IGF1; Igf-1; IGF1A; IGFI; Igf-I; IGFIa; IGF-IA; IGF-IB; insulin growth factor-1; Insulin like growth factor; insulin like growth factor 1; insulin-like growth factor 1; insulin-like growth factor 1 (somatomedin C); insulin-like growth factor I; insulin-like growth factor I (somatomedin C); insulin-like growth factor IB; mechano growth factor; MGF; M-IGF-1; OTTHUMP00000195084; prepro-IGF-I; prepro-insulin-like growth factor I; R-IGF-1; somatomedin; Somatomedin C; Somatomedin-C |
Biological Activity | The ED50 was determined by a cell proliferation assay using FDC-P1 cells is ≤ 2.0 ng/ml, corresponding to a specific activity of ≥ 5 x 10^5 units/mg |
Gene ID (Entrez) | 3479 |
Formulation | protein with no preservative |
Recombinant | Recombinant |
Content And Storage | -20°C |
---|---|
Purity or Quality Grade | ≥ 98% by SDS-PAGE gel and HPLC analyses. |
Conjugate | Unconjugated |
Form | Lyophilized |
Common Name | VEGF-121 |
Molecular Weight (g/mol) | 28.4 kDa |
Gene Symbol | VEGFA |
Endotoxin Concentration | <0.1 EU/ ÎĽg |
Sequence | APMAEGGGQN HHEVVKFMDV YQRSYCHPIE TLVDIFQEYP DEIEYIFKPS CVPLMRCGGC CNDEGLECVP TEESNITMQI MRIKPHQGQH IGEMSFLQHN KCECRPKKDR ARQENCDKPR R |
Expression System | E. coli |
For Use With (Application) | Functional Assay |
Source | E. coli |
Name | Human VEGF-121, Animal-Free |
Regulatory Status | RUO |
Gene Alias | H-VEGF-121; M-VEGF-121 |
Biological Activity | Determined by its ability to stimulate the proliferation of human umbilical vein endothelial cells (HUVEC). The expected ED50 for this effect is 1.0-5.0 ng/ml |
Formulation | protein with no preservative |
Recombinant | Recombinant |
Invitrogen™ Pepstatin A, BODIPY™ FL Conjugate
For the study of cathepsin D trafficking in cells by fluorescence microscopy
Content And Storage | -20°C |
---|---|
Purity or Quality Grade | ≥ 95% by SDS-PAGE gel and HPLC analyses. |
Conjugate | Unconjugated |
Form | Lyophilized |
Common Name | FGF10 |
Molecular Weight (g/mol) | 19.3 kDa |
Gene Symbol | FGF10 |
Endotoxin Concentration | <0.1 EU/ ÎĽg |
Sequence | MLGQDMVSPE ATNSSSSSFS SPSSAGRHVR SYNHLQGDVR WRKLFSFTKY FLKIEKNGKV SGTKKENCPY SILEITSVEI GVVAVKAINS NYYLAMNKKG KLYGSKEFNN DCKLKERIEE NGYNTYASFN WQHNGRQMYV ALNGKGAPRR GQKTRRKNTS AHFLPMVVHS |
Expression System | E. coli |
For Use With (Application) | Functional Assay |
Source | E. coli |
Name | Human FGF-10, Animal-Free |
Accession Number | O15520 |
Regulatory Status | RUO |
Gene Alias | AEY17; BB213776; FGF; Fgf10; FGF-10; Fibroblast growth factor; Fibroblast growth factor 10; Gsfaey17; Keratinocyte growth factor 2; produced by fibroblasts of urinary bladder lamina propria |
Biological Activity | Determined by the dose-dependent stimulation of thymidine uptake by BaF3 cells expressing FGF receptors. The expected ED50 is ≤ 0.5 ng/ml corresponding to a specific activity of ≥ 2 x 10^6 units/mg |
Gene ID (Entrez) | 2255 |
Formulation | protein with no preservative |
Recombinant | Recombinant |
Purity or Quality Grade | ≥ 95% by SDS-PAGE gel and HPLC analyses. |
---|---|
Conjugate | Unconjugated |
Form | Lyophilized |
Gene Symbol | Fgf4 |
Sequence | GRGGAAAPTA PNGTLEAELE RRWESLVALS LARLPVAAQP KEAAVQSGAG DYLLGIKRLR RLYCNVGIGF HLQALPDGRI GGAHADTRDS LLELSPVERG VVSIFGVASR FFVAMSSKGK LYGSPFFTDE CTFKEILLPN NYNAYESYKY PGMFIALSKN GKTKKGNRVS PTMKVTHFLP RL |
For Use With (Application) | ELISA,Functional Assay,Western Blot |
Source | E. coli |
Name | Human FGF-4 |
Accession Number | P08620 |
Regulatory Status | RUO |
Gene Alias | FGF; FGF4; Fgf-4; Fgfk; Fibroblast growth factor; fibroblast growth factor 4; fibroblast growth factor 4 splice isoform; HBGF-4; heparin secretory transforming protein 1; heparin secretory-transforming protein 1; heparin-binding growth factor 1; heparin-binding growth factor 4; HST; Hst1; hst-1; HSTF1; HSTF-1; human stomach cancer, transforming factor from FGF-related oncogene; kaposi sarcoma oncogene; Kfgf; K-FGF; K-fibroblast growth factor; KS3; oncogene HST; transforming protein KS3 |
Gene ID (Entrez) | 2249 |
Formulation | protein with no preservative |
Recombinant | Recombinant |
Invitrogen™ BODIPY™ 505/515 (4,4-Difluoro-1,3,5,7-Tetramethyl-4-Bora-3a,4a-Diaza-s-Indacene)
With its nonpolar structure and long-wavelength absorption and fluorescence, BODIPY™ 505/515 can be used as a stain for netural lipids and as a tracer for oil and other nonpolar lipids.